# EDGAR Filing Document

**Accession Number:** 0001413447
**File Stem:** 0001413447-26-000034
**Filing Date:** 2026-4
**Character Count:** 120939
**Document Hash:** d474812d87d6069db5445189fc3b99ac
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001413447-26-000034.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001413447-26-000034

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 82

**CONFORMED PERIOD OF REPORT**: 20260329

**FILED AS OF DATE**: 20260428

**DATE AS OF CHANGE**: 20260428

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NXP Semiconductors N.V.
- **CENTRAL INDEX KEY:** 0001413447
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34841
- **FILM NUMBER:** 26908270

**BUSINESS ADDRESS:**
- **BUSINESS PHONE:** 31 6 54 265349

**MAIL ADDRESS:**
- **STREET 1:** HIGH TECH CAMPUS 60
- **CITY:** EINDHOVEN
- **STATE:** P7
- **ZIP:** 5656AG

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** KASLION Acquisition B.V.
- **DATE OF NAME CHANGE:** 20070925

?xml version='1.0' encoding='ASCII'? nxpi-20260329

**UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q** 

(Mark One)

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended March 29, 2026

or

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>.

Commission File Number: **001-34841** 

**NXP Semiconductors N.V.** 

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Netherlands** | **98-1144352** |
| (State or other jurisdiction<br>of incorporation or organization) | (I.R.S. employer identification number) |
| **60 High Tech Campus** | **5656 AG** |
| **Eindhoven** | **5656 AG** |
| **Netherlands** | **5656 AG** |
| (Address of principal executive offices) | (Zip code) |

---

---

| | | | |
|:---|:---|:---|:---|
| | **+31** | **40** | **2729999** |
| (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) |

---

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading symbol(s) Name of each exchange on which registered <br> <u>Common shares, EUR 0.20 par value</u> <u>NXPI</u> <u>The Nasdaq Global Select Market</u>

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).

Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

------

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☒

As of April 24, 2026, there were 252,471,079 shares of our common stock, €0.20 par value per share, issued and outstanding.

------

**NXP Semiconductors N.V.**

**Form 10-Q**

**For the Fiscal Quarter Ended March 29, 2026** 

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **Page** |
| **<u>[Part I](#idbff79c4b47c468694a9071c16e72193_13)</u>** | **<u>[Part I](#idbff79c4b47c468694a9071c16e72193_13)</u>** | **<u>[Part I](#idbff79c4b47c468694a9071c16e72193_13)</u>** |
| | <u>[Introduction and Forward Looking Statements](#idbff79c4b47c468694a9071c16e72193_10)</u> | <u>[1](#idbff79c4b47c468694a9071c16e72193_10)</u> |
| <u>[Item 1.](#idbff79c4b47c468694a9071c16e72193_16)</u> | <u>[Financial Statements](#idbff79c4b47c468694a9071c16e72193_16)</u> | <u>[3](#idbff79c4b47c468694a9071c16e72193_16)</u> |
| <u>[Item 2.](#idbff79c4b47c468694a9071c16e72193_73)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#idbff79c4b47c468694a9071c16e72193_73)</u> | <u>[20](#idbff79c4b47c468694a9071c16e72193_73)</u> |
| <u>[Item 3.](#idbff79c4b47c468694a9071c16e72193_82)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#idbff79c4b47c468694a9071c16e72193_82)</u> | <u>[34](#idbff79c4b47c468694a9071c16e72193_82)</u> |
| <u>[Item 4.](#idbff79c4b47c468694a9071c16e72193_85)</u> | <u>[Controls and Procedures](#idbff79c4b47c468694a9071c16e72193_85)</u> | <u>[34](#idbff79c4b47c468694a9071c16e72193_85)</u> |
| **<u>[Part II](#idbff79c4b47c468694a9071c16e72193_88)</u>** | **<u>[Part II](#idbff79c4b47c468694a9071c16e72193_88)</u>** | **<u>[Part II](#idbff79c4b47c468694a9071c16e72193_88)</u>** |
| <u>[Item 1.](#idbff79c4b47c468694a9071c16e72193_91)</u> | <u>[Legal Proceedings](#idbff79c4b47c468694a9071c16e72193_91)</u> | <u>[35](#idbff79c4b47c468694a9071c16e72193_91)</u> |
| <u>[Item 1A.](#idbff79c4b47c468694a9071c16e72193_94)</u> | <u>[Risk Factors](#idbff79c4b47c468694a9071c16e72193_94)</u> | <u>[35](#idbff79c4b47c468694a9071c16e72193_94)</u> |
| <u>[Item 2.](#idbff79c4b47c468694a9071c16e72193_97)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#idbff79c4b47c468694a9071c16e72193_97)</u> | <u>[35](#idbff79c4b47c468694a9071c16e72193_97)</u> |
| <u>[Item 5.](#idbff79c4b47c468694a9071c16e72193_100)</u> | <u>[Other Information](#idbff79c4b47c468694a9071c16e72193_100)</u> | <u>[35](#idbff79c4b47c468694a9071c16e72193_100)</u> |
| <u>[Item 6.](#idbff79c4b47c468694a9071c16e72193_106)</u> | <u>[Exhibits](#idbff79c4b47c468694a9071c16e72193_106)</u> | <u>[36](#idbff79c4b47c468694a9071c16e72193_106)</u> |

---

------

**Introduction and Forward Looking Statements**

This Form 10-Q and certain information incorporated herein by reference contains forward-looking statements, which are provided under the "safe harbor" protection of the Private Securities Litigation Reform Act of 1995. When used in this Form 10-Q, the words "anticipate", "believe", "estimate", "forecast", "expect", "intend", "plan" and "project" and similar expressions, as they relate to us, our management or third parties, identify forward-looking statements. Forward-looking statements include statements regarding our business strategy, financial condition, results of operations, market data as well as any other statements that are not historical facts. These statements reflect beliefs of our management, as well as assumptions made by our management and information currently available to us. Although we believe that these beliefs and assumptions are reasonable, these statements are subject to numerous factors, risks and uncertainties that could cause actual outcomes and results to be materially different from those projected. These factors, risks and uncertainties expressly qualify all subsequent oral and written forward-looking statements attributable to us or persons acting on our behalf and include, in addition to those listed under Part I, Item 1A. *Risk Factors* in our Annual Report on Form 10-K for the year ended December 31, 2025 and elsewhere in this Form 10-Q, the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• market demand and semiconductor industry conditions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to successfully introduce new technologies and products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the demand for the goods into which our products are incorporated;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• recent changes in global trade policy including tariffs and related trade actions announced by the U.S., China and other countries, potential increase of barriers to international trade, including the imposition of new or increased tariffs, and resulting disruptions to our established supply chains;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of government actions and regulations, including as a result of executive orders, including restrictions on the export of products and technology;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increasing and evolving cybersecurity threats and privacy risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to accurately estimate demand and match our production capacity accordingly or obtain supplies from third-party producers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our access to production from third-party outsourcing partners, and any events that might affect their business or our relationship with them;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to secure adequate and timely supply of equipment and materials from suppliers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to avoid operational problems and product defects and, if such issues were to arise, to correct them quickly;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to form strategic partnerships and joint ventures and successfully cooperate with our strategic alliance partners;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to win competitive bid selection processes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to develop products for use in our customers' equipment and products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to successfully hire and retain key management and senior product engineers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• global hostilities, including the invasion of Ukraine by Russia and resulting regional instability, sanctions and any other retaliatory measures taken against Russia, and the continued hostilities and armed conflict in the Middle East including the ongoing military conflict involving Iran and the resulting disruption to energy markets, industrial gas supplies and global logistical routes, which could adversely impact the global supply chain, disrupt our operations or negatively impact the demand for our products in our primary end markets

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to maintain good relationships with our suppliers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to integrate acquired businesses in an efficient and effective manner;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to generate sufficient cash, raise sufficient capital or refinance our debt at or before maturity to meet our debt service, research and development and capital investment requirements; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a change in tax laws could have an effect on our estimated effective tax rates.

We do not assume any obligation to update any forward-looking statements and disclaim any obligation to update our view of any risks or uncertainties described herein or to publicly announce the result of any revisions to the forward-looking statements made in this Form 10-Q, except as required by law.

In addition, this Form 10-Q contains information concerning the semiconductor industry, our end markets and business generally, which is forward-looking in nature and is based on a variety of assumptions regarding the ways in which the semiconductor industry, our end markets and business will develop. We have based these assumptions on information currently available to us, including through the market research and industry reports referred to in this Form 10-Q. If any one or more of these assumptions turn out to be incorrect, actual market results may differ from those predicted. While we do not know what impact any such differences may have on our business, if there are such differences, they could have a material adverse effect on our future results of operations and financial condition, and the trading price of our common stock. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak to results only as of the date the statements were made. Except for any ongoing obligation to disclose material information as required by the United States federal securities laws, NXP does not have any intention or obligation to publicly update or revise any forward-looking statements after we file this document with the U.S. Securities and Exchange Commission, whether to reflect any future events or circumstances or otherwise.

------

The financial information included in this Form 10-Q is based on United States Generally Accepted Accounting Principles (U.S. GAAP), unless otherwise indicated.

In presenting and discussing our financial position, operating results and cash flows, management uses certain non-U.S. GAAP financial measures. These non-U.S. GAAP financial measures should not be viewed in isolation or as alternatives to the equivalent U.S. GAAP measures and should be used in conjunction with the most directly comparable U.S. GAAP measures. A discussion of non-U.S. GAAP measures included in this Form 10-Q and a reconciliation of such measures to the most directly comparable U.S. GAAP measures are set forth under "Use of Certain Non-GAAP Financial Measures" contained in this Form 10-Q under Item 2. *Management's Discussion and Analysis of Financial Condition and Results of Operations*.

Unless otherwise required, all references herein to "we", "our", "us", "NXP" and the "Company" are to NXP Semiconductors N.V. and its consolidated subsidiaries.

This Form 10-Q includes market data and certain other statistical information and estimates that are based on reports and other publications from industry analysts, market research firms, and other independent sources, as well as management's own good faith estimates and analyses. NXP believes these third-party reports to be reputable, but has not independently verified the underlying data sources, methodologies or assumptions. The reports and other publications referenced are generally available to the public and were not commissioned by NXP. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected in this information.

------

**PART I — FINANCIAL INFORMATION**

**Item 1.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)**

**($ in millions, unless otherwise stated)**

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 29, 2026** | **March 30, 2025** |
| Revenue | 3181 | 2835 |
| Cost of revenue | (1393) | (1275) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 1788 | 1560 |
| Research and development | (588) | (547) |
| Selling, general and administrative | (284) | (281) |
| Amortization of acquisition-related intangible assets | (32) | (27) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | (904) | (855) |
| Other income (expense) | 621 | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | 1505 | 723 |
| &nbsp;&nbsp;&nbsp;&nbsp;Financial income (expense): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other financial income (expense) | (96) | (92) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income (loss) before income taxes | 1409 | 631 |
| Benefit (provision) for income taxes | (272) | (130) |
| Results relating to equity-accounted investees | (4) | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | 1133 | 497 |
| Less: Net income (loss) attributable to non-controlling interests | 11 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to stockholders | 1122 | 490 |
| **Earnings per share data:** |  |  |
| *Net income (loss) per common share attributable to stockholders in $* |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 4.44 | 1.93 |
| &nbsp;&nbsp;&nbsp;Diluted | 4.43 | 1.92 |
| Weighted average number of shares of common stock outstanding during the period (in thousands): |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 252715 | 253709 |
| &nbsp;&nbsp;&nbsp;Diluted | 253525 | 255018 |

---

See accompanying notes to the Condensed Consolidated Financial Statements

------

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME** 

**(Unaudited)**

**($ in millions, unless otherwise stated)**

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 29, 2026** | **March 30, 2025** |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | 1133 | 497 |
| Other comprehensive income (loss), net of tax: |  |  |
| Change in fair value cash flow hedges | (4) | 3 |
| Change in foreign currency translation adjustment | (37) | 43 |
| Change in net actuarial gain (loss) | (1) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive income (loss) | (42) | 46 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total comprehensive income (loss) | 1091 | 543 |
| Less: Comprehensive income (loss) attributable to non-controlling interests | 11 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total comprehensive income (loss) attributable to stockholders | 1080 | 536 |

---

See accompanying notes to the Condensed Consolidated Financial Statements

------

**CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)**

**($ in millions, unless otherwise stated)**

---

| | | |
|:---|:---|:---|
| | **March 29, 2026** | **December 31, 2025** |
| **ASSETS** | | |
| **Current assets:** | | |
| Cash and cash equivalents | 3708 | 3267 |
| Accounts receivable, net | 1186 | 1055 |
| Assets held for sale | 91 | 372 |
| Inventories, net | 2523 | 2577 |
| Other current assets | 644 | 669 |
| **Total current assets** | 8152 | 7940 |
| **Non-current assets:** |  |  |
| Deferred tax assets | 1238 | 1213 |
| Other non-current assets | 3037 | 2584 |
| Property, plant and equipment, net of accumulated depreciation of $6,457 and $6,366 respectively | 2901 | 2977 |
| Identified intangible assets, net of accumulated amortization of $775 and $820 respectively | 1505 | 1547 |
| Goodwill | 10280 | 10299 |
| Total non-current assets | 18961 | 18620 |
| **Total assets** | 27113 | 26560 |
| **LIABILITIES AND EQUITY** |  |  |
| **Current liabilities:** |  |  |
| Accounts payable | 904 | 997 |
| Restructuring liabilities-current | 133 | 189 |
| Other current liabilities | 1851 | 1445 |
| Short-term debt | 750 | 1250 |
| **Total current liabilities** | 3638 | 3881 |
| **Non-current liabilities:** |  |  |
| Long-term debt | 10974 | 10972 |
| Restructuring liabilities | 76 | 81 |
| Other non-current liabilities | 1151 | 1175 |
| **Total non-current liabilities** | 12201 | 12228 |
| **Total liabilities** | 15839 | 16109 |
| **Equity:** |  |  |
| Non-controlling interests | 347 | 395 |
| Stockholders' equity: |  |  |
| Common stock, par value €0.20 per share: | 56 | 56 |
| Capital in excess of par value | 15537 | 15424 |
| Treasury shares, at cost: |  |  |
| 21,894,272 shares (2025: 21,664,934 shares) | (4341) | (4283) |
| Accumulated other comprehensive income (loss) | 171 | 213 |
| Accumulated deficit | (496) | (1354) |
| Total stockholders' equity | 10927 | 10056 |
| **Total equity** | 11274 | 10451 |
| **Total liabilities and equity** | 27113 | 26560 |

---

See accompanying notes to the Condensed Consolidated Financial Statements

------

 **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)**

**($ in millions, unless otherwise stated)**

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 29, 2026** | **March 30, 2025** |
| *Cash flows from operating activities:* |  |  |
| **Net income (loss)** | 1133 | 497 |
| Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 179 | 209 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 109 | 127 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of discount (premium) on debt, net | 1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs | 2 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (gain) loss on sale of assets | (627) | (22) |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on equity security, net | (1) | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Results relating to equity-accounted investees | 4 | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred tax expense (benefit) | (28) | (27) |
| *Changes in operating assets and liabilities:* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in receivables and other current assets | (115) | (29) |
| &nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in inventories | 87 | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in accounts payable and other liabilities | 231 | (110) |
| &nbsp;&nbsp;&nbsp;&nbsp;Decrease (increase) in other non-current assets | (182) | (106) |
| Exchange differences | 4 | 4 |
| Other items | (4) | 4 |
| **Net cash provided by (used for) operating activities** | 793 | 565 |
| *Cash flows from investing activities:* |  |  |
| Purchase of identified intangible assets | (42) | (25) |
| Capital expenditures on property, plant and equipment | (79) | (139) |
| Proceeds from disposals of property, plant and equipment |  | 1 |
| Proceeds from sale of interests in businesses, net of cash divested | 878 |  |
| Purchase of investments | (249) | (53) |
| **Net cash provided by (used for) investing activities** | 508 | (216) |
| *Cash flows from financing activities:* |  |  |
| Repurchase of long-term debt | (501) |  |
| Proceeds from the issuance of long-term debt |  | 370 |
| Cash paid for debt issuance costs | (3) |  |
| Proceeds from issuance of commercial paper notes |  | 646 |
| Repayment of commercial paper notes |  | (146) |
| Dividends paid to non-controlling interests | (29) |  |
| Dividends paid to common stockholders | (256) | (258) |
| Proceeds from issuance of common stock through stock plans | 36 | 37 |
| Purchase of treasury shares and restricted stock unit withholdings | (102) | (303) |
| Other, net | (1) | (1) |
| **Net cash provided by (used for) financing activities** | (856) | 345 |
| Effect of changes in exchange rates on cash positions | (4) | 2 |
| Increase (decrease) in cash and cash equivalents | 441 | 696 |
| Cash and cash equivalents at beginning of period | 3267 | 3292 |
| **Cash and cash equivalents at end of period** | 3708 | 3988 |

---

---

| | | |
|:---|:---|:---|
| Supplemental disclosures to the Condensed Consolidated Cash flows | Supplemental disclosures to the Condensed Consolidated Cash flows | Supplemental disclosures to the Condensed Consolidated Cash flows |
| ***Net cash paid during the period for:*** |  |  |
| Interest | 79 | 41 |
| Income taxes, net of refunds | 93 | 96 |
| ***Net gain (loss) on sale of assets:*** |  |  |
| Cash proceeds from the sale of assets | 878 | 31 |
| Non-cash consideration <sup>1)</sup> | 44 |  |
| Book value of these assets and transaction costs | (295) | (9) |
| ***Non-cash investing activities:*** |  |  |
| Non-cash capital expenditures | 87 | 108 |

---

1) Represents the fair value on the closing date of the earn-out receivable from the divestiture of our MEMS Sensors business

See accompanying notes to the Condensed Consolidated Financial Statements

------

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited)**

**($ in millions, unless otherwise stated)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Outstanding<br>number of<br>shares (in<br>thousands) | Common<br>stock | Capital in<br>excess of<br>par value | Treasury<br>shares at<br>cost | Accumu-<br>lated<br>other<br>compre-<br>hensive<br>income<br>(loss) | Accumu-<br>lated<br>deficit | Total<br>stock-<br>holders'<br>equity | Non-<br>con-<br>trolling<br>interests | Total<br>equity |
| **Balance as of December 31, 2025** | 252854 | 56 | 15424 | (4283) | 213 | (1354) | 10056 | 395 | 10451 |
| Net income (loss) |  |  |  |  |  | 1122 | 1122 | 11 | 1133 |
| Other comprehensive income (loss) |  |  |  |  | (42) |  | (42) |  | (42) |
| Share-based compensation plans |  |  | 113 |  |  |  | 113 |  | 113 |
| Shares issued pursuant to stock awards | 232 |  |  | 44 |  | (8) | 36 |  | 36 |
| Treasury shares repurchased and retired | (461) |  |  | (102) |  |  | (102) |  | (102) |
| Dividends non-controlling interest |  |  |  |  |  |  |  | (59) | (59) |
| Dividends common stock ($1.014 per share) |  |  |  |  |  | (256) | (256) |  | (256) |
| **Balance as of March 29, 2026** | 252625 | 56 | 15537 | (4341) | 171 | (496) | 10927 | 347 | 11274 |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Outstanding<br>number of<br>shares (in<br>thousands) | Common<br>stock | Capital in<br>excess of<br>par value | Treasury<br>shares at<br>cost | Accumu-<br>lated<br>other<br>compre-<br>hensive<br>income<br>(loss) | Accumu-<br>lated<br>deficit | Total<br>stock-<br>holders'<br>equity | Non-<br>con-<br>trolling<br>interests | Total<br>equity |
| **Balance as of December 31, 2024** | 254324 | 56 | 14962 | (4004) | (17) | (1814) | 9183 | 348 | 9531 |
| Net income (loss) |  |  |  |  |  | 490 | 490 | 7 | 497 |
| Other comprehensive income (loss) |  |  |  |  | 46 |  | 46 |  | 46 |
| Share-based compensation plans |  |  | 131 |  |  |  | 131 |  | 131 |
| Shares issued pursuant to stock awards | 238 |  |  | 54 |  | (22) | 32 |  | 32 |
| Treasury shares repurchased and retired | (1413) |  |  | (303) |  |  | (303) |  | (303) |
| Dividends common stock ($1.014 per share) |  |  |  |  |  | (257) | (257) |  | (257) |
| **Balance as of March 30, 2025** | 253149 | 56 | 15093 | (4253) | 29 | (1603) | 9322 | 355 | 9677 |

---

See accompanying notes to the Condensed Consolidated Financial Statements

------

**NXP SEMICONDUCTORS N.V.**

**NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**All amounts in millions of $ unless otherwise stated**

**1 Basis of Presentation and Overview**

We prepared our interim Condensed Consolidated Financial Statements that accompany these notes in conformity with U.S. generally accepted accounting principles, consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended December 31, 2025.

***Use of estimates***

We have made estimates and judgments affecting the amounts reported in our Condensed Consolidated Financial Statements and the accompanying notes. The actual results that we experience may differ materially from our estimates. The interim financial information is unaudited, but reflects all normal adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025.

***Segment reporting***

NXP has one reportable segment representing the entity as a whole, aligning with our organizational structure and with the way our chief operating decision maker ("CODM"), the Chief Executive Officer, makes operating decisions, allocates resources, and manages the growth and profitability of the Company.

Our CODM regularly reviews income and expense items at the consolidated company (reporting segment) level and uses net income to evaluate income generated from total assets to evaluate whether and how to reinvest profits into the entity's operations, shareholder return, acquisitions or otherwise. Net income is also used to monitor budget versus actual results, forecasted information and in competitive analysis. These interim income and expense items are included on the Consolidated Statements of Operations and in our notes to the Consolidated Financial Statements.

**2 Significant Accounting Policies and Recent Accounting Pronouncements**

***Significant Accounting Policies***

For a discussion of our significant accounting policies, see Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – "Significant Accounting Policies" of our Annual Report on Form 10-K for the year ended December 31, 2025. There have been no changes to our significant accounting policies since our Annual Report on Form 10-K for the year ended December 31, 2025.

***Recent accounting standards***

*Accounting standards not yet adopted*

In November 2024, the FASB issued Accounting Standards Update (ASU) 2024-03, Disaggregation of Income Statement Expenses. The standard requires disaggregated disclosure of income statement expenses. It requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, with early adoption permitted. We are currently evaluating the effect of this new guidance on our Consolidated Financial Statements.

No other new accounting pronouncements were issued or became effective in the period that had, or are expected to have, a material impact on our Consolidated Financial Statements.

**3 Acquisitions and Divestments**

***2026***

On February 2, 2026, we completed the sale of our MEMS Sensors business, previously classified as held for sale, pursuant to the definitive agreement with STMicroelectronics International N.V. dated July 24, 2025. At closing, we received $878 million in cash, with the potential to receive an additional $50 million contingent upon the achievement of specified post-closing technical milestones ("earn-out receivable"). The earn-out receivable was measured at fair value at closing and included in the consideration transferred, with subsequent changes in fair value recognized in earnings. This resulted in a gain on sale of $627 million recorded in "Other income (expense)" in the Consolidated Statements of Operations.

------

There were no material acquisitions during the first three months of 2026.

***2025***

*TTTech Auto acquisition*

On June 17, 2025, NXP announced the closing of the acquisition of 100% of TTTech Auto for $766 million in cash ($675 million net of cash acquired). TTTech Auto is a leader in innovating unique safety-critical systems and middleware for software-defined vehicles (SDVs). The TTTech Auto acquisition complements and expands NXP's system and software offerings in the Automotive and Industrial & IoT end markets.

The revised fair values of the assets acquired, and liabilities assumed in the TTTech Auto acquisition, by major class, were recognized as follows:

---

| | |
|:---|:---|
| Cash | 91 |
| Other assets | 75 |
| Other liabilities | (52) |
| Identified intangible assets | 347 |
| Goodwill | 305 |
| Net assets acquired | 766 |

---

Our valuation procedures related to the acquired assets and assumed liabilities was completed during the first quarter of 2026.

Goodwill arising from the TTTech Auto acquisition is attributed to the anticipated growth from new product sales, sales to new customers, the assembled workforce, and synergies expected from the combination. The goodwill recognized is non-deductible for income tax purposes.

The identified intangible assets assumed were recognized as follows:

---

| | | |
|:---|:---|:---|
| | **Fair value** | **Weighted Average Estimated Useful Life (in Years)** |
| Software | 267 | 11.5 |
| Technology | 25 | 11.5 |
| Customer relationships | 50 | 8.5 |
| Order backlog | 5 | 3.5 |
| **Total identified intangible assets** | **347** | **10.9** |

---

The income approach was applied to estimate the fair values of the intangible assets acquired. Software, technology, customer relationships, and order backlog were valued using the excess earnings method, which reflects the present values of the projected cash flows that are expected to be generated by the software, technology, customer relationships, and order backlog less charges representing the contribution of other assets to those cash flows.

*Aviva Links acquisition*

On October 24, 2025, NXP closed the previously announced acquisition of 100% of Aviva Links for $222 million in cash ($202 million net of cash acquired) and $26 million through the settlement of previously held investments in Aviva Links. Aviva Links is a provider of Automotive SerDes Alliance (ASA) compliant in-vehicle connectivity solutions. The Aviva Links acquisition complements and expands NXP's automotive networking solutions in the Automotive and Industrial & IoT end markets.

The fair values of the assets acquired, and liabilities assumed in the Aviva Links acquisition, by major class, were recognized as follows:

------

---

| | |
|:---|:---|
| Other assets | 20 |
| Other liabilities | (64) |
| In-Process R&D ("IPR&D") | 197 |
| Goodwill | 95 |
| Net assets acquired | 248 |

---

The purchase price allocation contains valuations related to certain assets and liabilities as some of the estimates and assumptions are subject to change within the measurement period as additional information becomes available.

Goodwill arising from the Aviva Links acquisition is attributed to the value related to new technological innovations from future product sales, sales to new customers, the assembled workforce, and synergies expected from the combination. The goodwill recognized is non-deductible for income tax purposes.

Acquired IPR&D is an intangible asset classified as an indefinite lived asset until the completion or abandonment of the associated research and development effort. IPR&D will be amortized over an estimated useful life to be determined at the date the associated research and development effort is completed, or expensed immediately when, and if, the project is abandoned. Acquired IPR&D is not amortized during the period that it is considered indefinite lived, but rather is subject to annual testing for impairment or when there are indicators for impairment.

The excess earnings method, a variant of the income approach, was applied to estimate the fair value of the IPR&D acquired. The fair value represents the present value of the projected cash flows that are expected to be generated by the IPR&D, adjusted for contributory asset charges related to other acquired assets.

*Kinara, Inc. acquisition*

On October 27, 2025, NXP closed the previously announced acquisition of 100% of Kinara, Inc. for $284 million in cash ($283 million net of cash acquired). Kinara is an industry leader in high performance, energy-efficient and programmable discrete neural processing units (NPUs). The Kinara acquisition complements and expands NXP's solutions for AI-powered edge systems in the Industrial & IoT and Automotive end markets.

The revised fair values of the assets acquired, and liabilities assumed in the Kinara acquisition, by major class, were recognized as follows:

---

| | |
|:---|:---|
| Other assets | 8 |
| Other liabilities | (59) |
| Identified intangible assets | 254 |
| Goodwill | 81 |
| Net assets acquired | 284 |

---

The purchase price allocation contains valuations related to certain assets and liabilities as some of the estimates and assumptions are subject to change within the measurement period as additional information becomes available.

Goodwill arising from the Kinara acquisition is attributed to the value related to new technological innovations from future product sales, sales to new customers, the assembled workforce, and synergies expected from the combination. The goodwill recognized is non-deductible for income tax purposes.

The identified intangible assets assumed were recognized as follows:

---

| | | |
|:---|:---|:---|
| | **Fair value** | **Weighted Average Estimated Useful Life (in Years)** |
| Existing Technology | 191 | 9.2 |
| IPR&D<sup>1</sup> | 56 | N/A |
| Customer relationships | 7 | 8.2 |
| **Total identified intangible assets** | **254** | **9.2** |

---

------

<sup>1</sup> IPR&D is an intangible asset classified as an indefinite lived asset until the completion or abandonment of the associated research and development effort. IPR&D will be amortized over an estimated useful life to be determined at the date the associated research and development effort is completed, or expensed immediately when, and if, the project is abandoned. Acquired IPR&D is not amortized during the period that it is considered indefinite lived, but rather is subject to annual testing for impairment or when there are indicators for impairment.

The excess earnings method, a variant of the income approach, was applied to estimate the fair values of the technology and IPR&D. The fair values represent the present values of the projected cash flows that are expected to be generated by the technology or IPR&D, adjusted for contributory asset charges related to other acquired assets. In addition, the existing customer relationships are valued using the distributor method, a variant of the income approach, in which a market-based distributor profit margin is used to allocate profits to this intangible asset.

*Divestments*

There were no material divestments during 2025.

**4 Assets Held for Sale**

During the fourth quarter of 2025, NXP management committed to selling the buildings and land at our Oak Hill site in Austin, Texas. The carrying amount of the site of $74 million was classified as held for sale and continues to be presented within current assets, representing the majority of the assets classified as held for sale as of March 29, 2026. The asset is available for immediate sale, is being actively marketed, and management expects the sale to be completed within the next six months.

------

**5 Supplemental Financial Information**

*Statement of Operations Information:*

***Disaggregation of revenue***

The following table presents revenue disaggregated by sales channel:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 29, 2026** | **March 30, 2025** |
| Distributors | 1862 | 1524 |
| Direct | 1282 | 1284 |
| Other | 37 | 27 |
| **Total - Revenue** | 3181 | 2835 |

---

***Depreciation, amortization and impairment***

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 29, 2026** | **March 30, 2025** |
| Depreciation of property, plant and equipment | 109 | 143 |
| Amortization of internal use software | 13 | 8 |
| Amortization of other identified intangible assets | 57 | 58 |
| **Total - Depreciation, amortization and impairment** | 179 | 209 |

---

***Financial income and expense***

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 29, 2026** | **March 30, 2025** |
| Interest income | 31 | 35 |
| Interest expense | (114) | (106) |
| Other financial income (expense) | (13) | (21) |
| **Total - Financial income (expense)** | (96) | (92) |

---

------

***Earnings per share***

The computation of earnings per share (EPS) is presented in the following table:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 29, 2026** | **March 30, 2025** |
| Net income (loss) | 1133 | 497 |
| Less: net income (loss) attributable to non-controlling interests | 11 | 7 |
| Net income (loss) attributable to stockholders | 1122 | 490 |
| Weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands) | 252715 | 253709 |
| Plus incremental shares from assumed conversion of: |  |  |
| Options <sup>1)</sup> | 4 | 94 |
| Restricted Share Units, Performance Share Units and Equity Rights <sup>2)</sup> | 806 | 1215 |
| Dilutive potential common shares | 810 | 1309 |
| Adjusted weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands) | 253525 | 255018 |
| *EPS attributable to stockholders in $:* |  |  |
| Basic net income (loss) | 4.44 | 1.93 |
| Diluted net income (loss) | 4.43 | 1.92 |

---

<sup>1)</sup>&nbsp;&nbsp;&nbsp;&nbsp;There were no stock options to purchase shares of NXP's common stock that were outstanding in Q1 2026 (Q1 2025: no stock options to purchase shares) that were anti-dilutive and were not included in the computation of diluted EPS because the exercise price was greater than the average fair market value of the common stock or the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense and exercise prices were greater than the weighted average number of shares underlying outstanding stock options.

<sup>2)</sup>&nbsp;&nbsp;&nbsp;&nbsp;There were no unvested RSUs, PSUs and equity rights that were outstanding in Q1 2026 (Q1 2025: no unvested RSU's, PSU's and equity rights) that were anti-dilutive and were not included in the computation of diluted EPS because the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense were greater than the weighted average number of outstanding unvested RSUs, PSUs and equity rights or the performance goal has not been met.

*Balance Sheet Information*

***Cash and cash equivalents***

At March 29, 2026, and December 31, 2025, our cash balance was $3,708 million and $3,267 million, respectively, of which $326 million and $361 million was held by SSMC, our consolidated joint venture company with TSMC. Under the terms of our joint venture agreement with TSMC, a portion of this cash can be distributed by way of a dividend to us, but 38.8% of the dividend will be paid to our joint venture partner. During 2025, no dividend was paid by SSMC. During the first quarter of 2026, SSMC declared a dividend of $150 million, of which $75 million was paid in the first quarter, with 38.8% being paid to our joint venture partner.

***Inventories***

Inventories are summarized as follows:

---

| | | |
|:---|:---|:---|
| | **March 29, 2026** | **December 31, 2025** |
| Raw materials | 97 | 92 |
| Work in process | 1,802 | 1,778 |
| Finished goods | 624 | 707 |
| | 2,523 | 2,577 |

---

The amounts recorded above are net of allowance for obsolescence of $141 million as of March 29, 2026 (December 31, 2025: $152 million).

------

***Equity Investments***

At March 29, 2026, and December 31, 2025, the total carrying value of investments in equity securities is summarized as follows:

---

| | | |
|:---|:---|:---|
| | **March 29, 2026** | **December 31, 2025** |
| Marketable equity securities | 2 | 1 |
| Non-marketable equity securities | 162 | 118 |
| Equity-accounted investments | 1,017 | 826 |
| | 1,181 | 945 |

---

&nbsp;&nbsp;&nbsp;&nbsp;

The total carrying value of investments in equity-accounted investees is summarized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 29, 2026** | **March 29, 2026** | **December 31, 2025** | **December 31, 2025** |
| | **Shareholding %** | **Amount** | **Shareholding %** | **Amount** |
| VisionPower Semiconductor Manufacturing Company Pte. Ltd. (VSMC) | 40.00% | 817 | 40.00% | 623 |
| European Semiconductor Manufacturing Company (ESMC) GmbH <sup>1)</sup> | 10.00% | 176 | 10.00% | 180 |
| Others |  | 24 |  | 23 |
|  |  | 1017 |  | 826 |
| <sup>1)</sup> NXP accounts for its investment in ESMC under the equity method due to our ability to exercise significant influence over ESMC's operations, primarily through representation on ESMC's shareholders' committee and other operational arrangements. | <sup>1)</sup> NXP accounts for its investment in ESMC under the equity method due to our ability to exercise significant influence over ESMC's operations, primarily through representation on ESMC's shareholders' committee and other operational arrangements. | <sup>1)</sup> NXP accounts for its investment in ESMC under the equity method due to our ability to exercise significant influence over ESMC's operations, primarily through representation on ESMC's shareholders' committee and other operational arrangements. | <sup>1)</sup> NXP accounts for its investment in ESMC under the equity method due to our ability to exercise significant influence over ESMC's operations, primarily through representation on ESMC's shareholders' committee and other operational arrangements. | <sup>1)</sup> NXP accounts for its investment in ESMC under the equity method due to our ability to exercise significant influence over ESMC's operations, primarily through representation on ESMC's shareholders' committee and other operational arrangements. |

---

------

Results related to equity-accounted investees at the end of each period were as follows:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 29, 2026** | **March 30, 2025** |
| Company's share in income (loss) | (4) | (4) |
| Other results |  |  |
|  | (4) | (4) |

---

***Other current liabilities*** 

Other current liabilities at March 29, 2026, and December 31, 2025, consisted of the following:

---

| | | |
|:---|:---|:---|
| | **March 29, 2026** | **December 31, 2025** |
| Accrued compensation and benefits | 470 | 393 |
| Dividend payable | 256 | 256 |
| Customer programs | 150 | 57 |
| Income taxes payable | 260 | 83 |
| Other | 715 | 656 |
| | 1,851 | 1,445 |

---

***Accumulated other comprehensive income (loss)*** 

Total comprehensive income (loss) represents net income (loss) plus the results of certain equity changes not reflected in the Condensed Consolidated Statements of Operations. The after-tax components of accumulated other comprehensive income (loss) and their corresponding changes are shown below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Currency <br>translation<br>differences** | **Change in<br>fair value<br>cash flow<br>hedges** | **Net actuarial<br>gain/(losses)** | **Accumulated <br>Other<br>Comprehensive<br>Income (loss)** |
| As of December 31, 2025 | 247 | 2 | (36) | 213 |
| Other comprehensive income (loss) before<br> reclassifications | (37) | (3) | (1) | (41) |
| Amounts reclassified out of accumulated other<br> comprehensive income (loss) |  | (2) |  | (2) |
| Tax effects |  | 1 |  | 1 |
| Other comprehensive income (loss) | (37) | (4) | (1) | (42) |
| As of March 29, 2026 | 210 | (2) | (37) | 171 |

---

***Cash dividends***

The following dividends were declared during the first three months of 2026 and 2025 under NXP's quarterly dividend program:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fiscal Year 2026** | **Fiscal Year 2026** | **Fiscal Year 2025** | **Fiscal Year 2025** |
| | **Dividend per share** | **Amount** | **Dividend per share** | **Amount** |
| First quarter | 1.014 | 256 | 1.014 | 257 |

---

The dividend declared in the first quarter (not yet paid) is classified in the Condensed Consolidated Balance Sheet in other current liabilities as of March 29, 2026, and was subsequently paid on April 9, 2026.

------

**6 Restructuring**

At each reporting date, we evaluate our restructuring liabilities, which consist primarily of termination benefits, to ensure that our accruals are still appropriate.

The following table presents the changes in restructuring liabilities in 2026:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **As of January 1, 2026** | **Additions** | **Utilized** | **Released** | **Other<br>changes** | **As of March 29, 2026** |
| Restructuring liabilities | 270 | 3 | (62) | (1) | (1) | 209 |

---

The total restructuring liability as of March 29, 2026, of $209 million is classified in the Consolidated Balance Sheet under current liabilities ($133 million) and non-current liabilities ($76 million).

The Company has ongoing restructuring initiatives aimed at streamlining manufacturing capacity, reducing costs, and aligning resources with strategic priorities. These initiatives primarily consist of workforce reductions, facility consolidations, and other cost-saving measures. During the first quarter of 2026, the restructuring provision decreased by $61 million, primarily reflecting the execution of previously announced involuntary restructuring programs. The restructuring charges for the three-month period ending March 30, 2025 primarily consist of $14 million for personnel related costs for specific targeted actions.

These restructuring charges recorded in operating income, for the periods indicated, are included in the following line items in the Statement of Operations:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 29, 2026** | **March 30, 2025** |
| Cost of revenue | (1) | 4 |
| Research and development | 2 | 7 |
| Selling, general and administrative | 1 | 3 |
| Net restructuring charges | 2 | 14 |

---

**7 Income Tax**

Each year, NXP makes an estimate of its annual effective tax rate. This estimated annual effective tax rate ("EAETR") is then applied to the year-to-date income (loss) before income taxes excluding discrete items, to determine the year-to-date benefit (provision) for income taxes. The income tax effects of any discrete items are recognized in the interim period in which they occur. As the year progresses, the Company continually refines the EAETR based upon actual events and the apportionment of our earnings (loss). This continual estimation process periodically may result in a change to our EAETR for the year. When this occurs, we adjust on an accumulated basis the benefit (provision) for income taxes during the quarter in which the change occurs.

Our provision for income taxes for 2026 is based on our EAETR of 19.9%, which is lower than the Netherlands statutory tax rate of 25.8%, primarily due to tax benefits from the Netherlands and foreign tax incentives.

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 29, 2026** | **March 30, 2025** |
| Tax benefit (provision) calculated at EAETR | (280) | (119) |
| Discrete tax benefit (provision) items | 8 | (11) |
| Benefit (provision) for income taxes | (272) | (130) |
| Effective tax rate | 19.3% | 20.6% |

---

The effective tax rate of 19.3% for the first quarter of 2026 was lower than the EAETR due to the income tax benefit for discrete items of $8 million. The discrete items are primarily related to the impact of foreign currency on income tax related items and changes in estimates for previous years.

The effective tax rate for the first quarter of 2026 was 19.3% compared to 20.6% for the same period in 2025, with discrete items in the respective periods impacting the rates accordingly. Excluding discrete items, the EAETR increased to 19.9% in 2026 from 18.8% in 2025, mainly as a result of a taxable capital gain and non-deductible goodwill associated with the divestiture of the MEMS Sensors business in the first quarter of 2026.

------

**8 Identified Intangible Assets**

Identified intangible assets as of March 29, 2026, and December 31, 2025, respectively, were composed of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 29, 2026** | **March 29, 2026** | **December 31, 2025** | **December 31, 2025** |
| | **Gross<br> carrying<br>amount** | **Accumulated<br>amortization** | **Gross carrying<br>amount** | **Accumulated<br>amortization** |
| In-process R&D (IPR&D) <sup>1)</sup> | 277 |  | 276 |  |
| Customer-related | 834 | (441) | 835 | (428) |
| Technology-based | 1169 | (334) | 1256 | (392) |
| Identified intangible assets | 2280 | (775) | 2367 | (820) |
| <sup>1)</sup> IPR&D is not subject to amortization until completion or abandonment of the associated research and development effort. | <sup>1)</sup> IPR&D is not subject to amortization until completion or abandonment of the associated research and development effort. | <sup>1)</sup> IPR&D is not subject to amortization until completion or abandonment of the associated research and development effort. | <sup>1)</sup> IPR&D is not subject to amortization until completion or abandonment of the associated research and development effort. | <sup>1)</sup> IPR&D is not subject to amortization until completion or abandonment of the associated research and development effort. |

---

The estimated amortization expense for these identified intangible assets for each of the five succeeding years is:

---

| | |
|:---|:---|
| 2026 (remaining) | 208 |
| 2027 | 254 |
| 2028 | 195 |
| 2029 | 131 |
| 2030 | 126 |
| Thereafter | 590 |

---

All intangible assets, excluding IPR&D and goodwill, are subject to amortization and have no assumed residual value.

The expected weighted average remaining life of identified intangibles is 7 years as of March 29, 2026 (December 31, 2025: 7 years).

**9 Debt**

**Commercial Paper**

We have a $2 billion Commercial Paper Program to support general corporate purposes. As of March 29, 2026, we had no commercial paper notes outstanding (December 31, 2025: no notes outstanding).

**Debt issuance and redemption**

On January 5, 2026, we repaid the $500 million aggregate principal amount of outstanding 5.35% senior unsecured notes due March 1, 2026, at par using available cash.

On February 6, 2026, NXP B.V., together with NXP Funding LLC, amended and restated its revolving credit agreement entered into on August 26, 2022. The amended and restated revolving credit agreement provides for $3 billion of senior unsecured revolving credit commitments and is scheduled to mature on February 6, 2031.

On April 20, 2026, we repaid $750 million aggregate principal amount of outstanding 3.875% senior unsecured notes due June 18, 2026, at par using available cash.

------

**Long-term debt**

The following table summarizes the outstanding debt as of March 29, 2026, and December 31, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **March 29, 2026** | **March 29, 2026** | **December 31, 2025** | **December 31, 2025** |
| | **Maturities** | **Amount** | **Interest<br>rate** | **Amount** | **Interest<br>rate** |
| Fixed-rate 5.35% senior unsecured notes | Mar, 2026 |  | 5.350 | 500 | 5.350 |
| Fixed-rate 3.875% senior unsecured notes | Jun, 2026 | 750 | 3.875 | 750 | 3.875 |
| Fixed-rate 3.15% senior unsecured notes | May, 2027 | 500 | 3.150 | 500 | 3.150 |
| Fixed-rate 4.40% senior unsecured notes | Jun, 2027 | 500 | 4.400 | 500 | 4.400 |
| Fixed-rate 4.30% senior unsecured notes | Aug, 2028 | 500 | 4.300 | 500 | 4.300 |
| Fixed-rate 5.55% senior unsecured notes | Dec, 2028 | 500 | 5.550 | 500 | 5.550 |
| Fixed-rate 4.3% senior unsecured notes | Jun, 2029 | 1000 | 4.300 | 1000 | 4.300 |
| Fixed-rate 3.4% senior unsecured notes | May, 2030 | 1000 | 3.400 | 1000 | 3.400 |
| Fixed-rate 2.5% senior unsecured notes | May, 2031 | 1000 | 2.500 | 1000 | 2.500 |
| Fixed-rate 2.65% senior unsecured notes | Feb, 2032 | 1000 | 2.650 | 1000 | 2.650 |
| Fixed-rate 4.85% senior unsecured notes | Aug, 2032 | 300 | 4.850 | 300 | 4.850 |
| Fixed-rate 5.0% senior unsecured notes | Jan, 2033 | 1000 | 5.000 | 1000 | 5.000 |
| Fixed-rate 5.25% senior unsecured notes | Aug, 2035 | 700 | 5.250 | 700 | 5.250 |
| Fixed-rate 3.25% senior unsecured notes | May, 2041 | 1000 | 3.250 | 1000 | 3.250 |
| Fixed-rate 3.125% senior unsecured notes | Feb, 2042 | 499 | 3.125 | 500 | 3.125 |
| Fixed-rate 3.25% senior unsecured notes | Nov, 2051 | 500 | 3.250 | 500 | 3.250 |
| Floating-rate revolving credit facility (RCF) | Aug, 2027 |  |  |  |  |
| Fixed-rate 4.45% EIB Facility A Loan | Dec, 2030 | 670 | 4.450 | 670 | 4.450 |
| Fixed-rate 4.709% EIB Facility B Loan | Feb, 2031 | 370 | 4.709 | 370 | 4.709 |
| Total principal |  | 11789 |  | 12290 |  |
| Unamortized discounts, premiums and debt<br> issuance costs |  | (65) |  | (68) |  |
| Total debt, including unamortized discounts,<br> premiums, debt issuance costs and fair value<br> adjustments |  | 11724 |  | 12222 |  |
| Current portion of long-term debt |  | (750) |  | (1250) |  |
| Long-term debt |  | 10974 |  | 10972 |  |

---

**10 Related-Party Transactions** 

The Company's related parties are the members of the board of directors of NXP Semiconductors N.V., the executive officers of NXP Semiconductors N.V. and equity-accounted investees.

The following table presents the amounts related to revenue and other income and purchase of goods and services incurred in transactions with these related parties:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 29, 2026** | **March 30, 2025** |
| Revenue and other income | 1 | 1 |
| Purchase of goods and services | 1 | 1 |

---

The following table presents the amounts related to receivable and payable balances with these related parties:

---

| | | |
|:---|:---|:---|
| | **March 29, 2026** | **December 31, 2025** |
| Receivables |  | 1 |
| Payables | 3 | 3 |

---

------

Driven by our investment in VSMC, NXP has committed to contribute $1,200 million to support the long-term capacity infrastructure, and in exchange NXP secures a capacity commitment over the lifetime of the factory. NXP has contributed $189 million during the three months ended March 29, 2026, and $1,044 million to-date, which is recorded in other non-current assets.

Refer to Note 5 – Supplemental Financial Information for information on the total carrying value of investments in equity-accounted investees, and to Note 12 – Commitments and Contingencies for NXP's related party commitments.

**11 Fair Value Measurements**

The following table summarizes the estimated fair value of our financial instruments which are measured at fair value on a recurring basis:

---

| | | | |
|:---|:---|:---|:---|
| | | **Estimated fair value** | **Estimated fair value** |
| | **Fair value<br>hierarchy** | **March 29, 2026** | **December 31, 2025** |
| **Assets:** | | | |
| Money market funds | 1 | 1713 | 1757 |
| Marketable equity securities | 1 | 2 | 1 |
| Derivative instruments-assets | 2 | 6 | 9 |
| Earn-out receivable | 3 | 44 |  |
| **Liabilities:** |  |  |  |
| Derivative instruments-liabilities | 2 | (13) | (11) |

---

The following methods and assumptions were used to estimate the fair value of financial instruments:

***Assets and liabilities measured at fair value on a recurring basis***

Money market funds (as part of our cash and cash equivalents) and marketable equity securities (as part of other non-current assets) have fair value measurements which are all based on quoted prices in active markets for identical assets or liabilities. For derivatives (as part of other current assets or accrued liabilities) the fair value is based upon significant other observable inputs depending on the nature of the derivative. The up to $50 million earn-out receivable related to the divested MEMS sensor business in the first quarter of 2026 is measured at fair value using Level 3 inputs.

***Assets and liabilities recorded at fair value on a non-recurring basis***

We measure and record our non-marketable equity securities, equity method investments and non-financial assets, such as intangible assets and property, plant and equipment, at fair value when an impairment charge is required.

***Assets and liabilities not recorded at fair value on a recurring basis***

Financial instruments not recorded at fair value on a recurring basis include non-marketable equity securities and equity method investments that have not been remeasured or impaired in the current period and debt.

As of March 29, 2026, the estimated fair value of current and non-current debt was $10.9 billion ($11.6 billion as of December 31, 2025). The fair value is estimated on the basis of broker-dealer quotes and other observable inputs, which are Level 2 inputs. Accrued interest is included under accrued liabilities and not within the carrying amount or estimated fair value of debt.

**12 Commitments and Contingencies**

***Purchase Commitments***

The Company maintains purchase commitments with certain suppliers, primarily for raw materials, semi-finished goods and manufacturing services and for some non-production items. Purchase commitments for inventory materials are generally restricted to a forecasted time-horizon as mutually agreed upon between the parties. This forecasted time horizon can vary for different suppliers. As of March 29, 2026, other than foundry joint venture commitments, the Company had purchase commitments of $2,881 million, which are due through 2044.

***Foundry Joint Venture Commitments***

Driven by our investment in VSMC, NXP has committed to invest an additional $773 million in equity through 2027. NXP has committed to contribute an additional $156 million to support the long-term capacity infrastructure that is expected to be paid through 2026. In addition, NXP has an agreed purchase commitment with VSMC that over the lifetime of the factory the

------

minimal loading will be between 80% - 90%, resulting in a total purchase commitment of approximately $14,096 million that is expected to be purchased over 37 years once wafer production starts.

Related to our investment in ESMC, NXP has committed to invest an additional $398 million in equity through 2029.

***Lease Commitments***

The Company has operating and finance lease arrangements related to buildings (corporate offices, research and development and manufacturing facilities and datacenters), land, machinery and installations and other equipment (vehicles and certain office equipment). As of March 29, 2026, amounts related to future lease payments for operating lease obligations totaled $683 million (December 31, 2025: $519 million), which are due through 2048. The increase is primarily attributable to the execution of new relocation lease agreements during the first quarter of 2026.

***Legal Proceedings***

We are regularly involved as plaintiffs or defendants in claims and litigation relating to a variety of matters such as contractual disputes, personal injury claims, employee grievances and intellectual property litigation. In addition, our acquisitions, divestments and financial transactions sometimes result in, or are followed by, claims or litigation. Some of these claims may possibly be recovered from insurance reimbursements. Although the ultimate disposition of asserted claims cannot be predicted with certainty, it is our belief that the outcome of any such claims, either individually or on a combined basis, will not have a material adverse effect on our consolidated financial position. However, such outcomes may be material to our consolidated statement of operations for a particular period. The Company records an accrual for any claim that arises whenever it considers that it is probable that it is exposed to a loss contingency, and the amount of the loss contingency can be reasonably estimated. The Company does not record a gain contingency until the period in which all contingencies are resolved, and the gain is realized or realizable. Legal fees are expensed when incurred.

*Motorola Personal Injury Lawsuits*

The Company has assisted Motorola in the defense of personal injury lawsuits pursuant to indemnity obligations under the agreement that separated Freescale from Motorola in 2004. All pending cases were settled as of the end of the first quarter of 2026. As a result, there are no remaining pending lawsuits related to these matters. Accordingly, the Company does not anticipate any further financial impact arising from these claims once settled. A portion of any indemnity due to Motorola will be reimbursed to NXP if Motorola receives an indemnification payment from its insurance coverage.

*Legal Proceedings Related Accruals and Insurance Coverage*

The Company reevaluates at least on a quarterly basis the claims that have arisen to determine whether any new accruals need to be made or whether any accruals made need to be adjusted based on the most current information available to it and based on its best estimate. Based on the procedures described above, the Company has an aggregate amount of $76 million accrued for potential and current legal proceedings as of March 29, 2026, compared to $75 million accrued at December 31, 2025 (without reduction for any related insurance reimbursements). The accruals are included in "Other current liabilities" and in "Other non-current liabilities". As of March 29, 2026, the Company's related balance of insurance reimbursements was $67 million (December 31, 2025: $56 million) and is included in "Other current assets".

The Company also estimates the aggregate range of reasonably possible losses in excess of the amount accrued based on currently available information for those cases for which such estimate can be made. Given that the known pending legal proceedings with a potentially material aggregate exposure of possible losses were settled during the quarter, the Company does not reasonably anticipate any additional potential aggregate exposure of possible loss in excess of the amount accrued.

**Item 2.&nbsp;&nbsp;&nbsp;&nbsp;Management's Discussion and Analysis of Financial Condition and Results of Operations** 

*Management's Discussion and Analysis (MD&A) should be read in conjunction with our Consolidated Financial Statements and Notes and the MD&A in our Annual Report on Form 10-K for the year ended* December 31, 2025*, and the Financial Statements and the related Notes that appear elsewhere in this document.*

**Overview**

------

***Quarterly Financial Highlights***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenue was $3,181 million, up 12.2% year-on-year;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• GAAP gross margin was 56.2%, and GAAP operating margin was 47.3%;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP gross margin was 57.1%, and non-GAAP operating margin was 33.1%;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash flow from operations was $793 million, with net capital expenditures on property, plant and equipment of $79 million, resulting in non-GAAP free cash flow of $714 million;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• During the first quarter of 2026, NXP returned capital to shareholders with the payment of $256 million in cash dividends and the repurchase of $102 million of its common shares, for a total capital return of $358 million.

On February 2, 2026, we completed the sale of our MEMS Sensors business, resulting in cash proceeds of $878 million at closing and a gain on sale of $627 million recorded in Other income (expense). See Note 3 to the Consolidated Financial Statements for further information regarding NXP's sale of the MEMS Sensors business.

------

![2613](nxpi-20260329_g1.jpg)

![2615](nxpi-20260329_g2.jpg)![2616](nxpi-20260329_g3.jpg)![2617](nxpi-20260329_g4.jpg)

***Sequential Results***

<u>Q1 2026 compared to Q4 2025</u>

Revenue for the three months ended March 29, 2026, was $3,181 million compared to $3,335 million for the three months ended December 31, 2025, a decrease of $154 million or 4.6% quarter-on-quarter, in line with management's expectations. Within our end markets, the Communication Infrastructure & Other end market increased $46 million or 13.8%, the Industrial & IoT end market decreased $12 million or 1.9%, the Automotive end market decreased $94 million or 5.0%, and the Mobile end market decreased $94 million or 19.4%.

When aggregating all end markets together and reviewing sales channel performance, revenue from distributors was $1,862 million, a decrease of $163 million or 8.0% compared to the previous period. Revenue from direct customers was $1,282 million, an increase of $8 million or 0.6% versus the previous period.

From a geographic perspective, the decrease of revenue quarter-on-quarter was driven by the China region with a decline of 15.7% and by the Asia Pacific region with a decrease of 6.6%.

Our gross profit percentage for the three months ended March 29, 2026, of 56.2% increased compared to 54.2% for the three months ended December 31, 2025, driven mainly by impairments related to the scaling down of a non-strategic product line in the fourth quarter of 2025.

Operating income for the three months ended March 29, 2026, was $1,505 million compared to $744 million for the three months ended December 31, 2025, an increase of $761 million or 102.3%. The sequential increase was mainly driven by the gain on sale of the MEMS Sensors business and lower restructuring expenses.

------

**Results of operations**

The following table presents operating results for each of the three-month periods ended March 29, 2026, and March 30, 2025, respectively:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ($ in millions, unless otherwise stated) | **Q1 2026** | **% of Revenue** | **Q1 2025** | **% of Revenue** |
| Revenue | 3181 |  | 2835 |  |
| % nominal growth | 12.2 |  | (9.3) |  |
| Gross profit | 1788 |  | 1560 |  |
| Gross margin | 56.2% |  | 55.0% |  |
| Research and development | (588) | 18.5% | (547) | 19.3% |
| Selling, general and administrative | (284) | 8.9% | (281) | 9.9% |
| Amortization of acquisition-related intangible assets | (32) | 1.0% | (27) | 1.0% |
| Other income (expense) | 621 | 19.5% | 18 | 0.6% |
| Operating income (loss) | 1505 | 47.3% | 723 | 25.5% |
| Financial income (expense) | (96) | 3.0% | (92) | 3.2% |
| Benefit (provision) for income taxes | (272) | 8.6% | (130) | 4.6% |
| Results relating to equity-accounted investees | (4) | 0.1% | (4) | 0.1% |
| Net income (loss) | 1133 | 35.6% | 497 | 17.5% |
| Less: Net income (loss) attributable to non-controlling interests | 11 | 0.3% | 7 | 0.2% |
| Net income (loss) attributable to stockholders | 1122 | 35.3% | 490 | 17.3% |
| Diluted earnings per share | 4.43 |  | 1.92 |  |

---

------

***Revenue***

Q1 2026 Overview

![4272](nxpi-20260329_g5.jpg)![4273](nxpi-20260329_g6.jpg)![4274](nxpi-20260329_g7.jpg)

<u>Q1 2026 compared to Q1 2025</u>

Revenue for the three months ended March 29, 2026, was $3,181 million compared to $2,835 million for the three months ended March 30, 2025, an increase of $346 million or 12.2%, in line with management's expectations.

Revenue by end market was as follows:

---

| | | | |
|:---|:---|:---|:---|
| ($ in millions, unless otherwise stated) | **Q1 2026** | **Q1 2025** | **% change** |
| Automotive | 1782 | 1674 | 6.5% |
| Industrial & IoT | 628 | 508 | 23.6% |
| Mobile | 391 | 338 | 15.7% |
| Communication Infrastructure & Other | 380 | 315 | 20.6% |
| Total Revenue | 3181 | 2835 | 12.2% |

---

Revenue by sales channel was as follows:

---

| | | | |
|:---|:---|:---|:---|
| ($ in millions, unless otherwise stated) | **Q1 2026** | **Q1 2025** | **% change** |
| Distributors | 1862 | 1524 | 22.2% |
| Direct | 1282 | 1284 | (0.2)% |
| Other | 37 | 27 | 37.0% |
| Total Revenue | 3181 | 2835 | 12.2% |

---

Revenue by geographic region, which is based on the location where the sale originated and where critical commercial decisions are made, was as follows:

---

| | | | |
|:---|:---|:---|:---|
| ($ in millions, unless otherwise stated) | **Q1 2026** | **Q1 2025** | **% change** |
| Americas | 958 | 749 | 27.9% |
| APAC, excluding China | 885 | 828 | 6.9% |
| EMEA (Europe, the Middle East and Africa) | 859 | 792 | 8.5% |
| China <sup>1)</sup> | 479 | 466 | 2.8% |
| Total Revenue | 3181 | 2835 | 12.2% |
| <sup>1)</sup> China includes Mainland China and Hong Kong | <sup>1)</sup> China includes Mainland China and Hong Kong | <sup>1)</sup> China includes Mainland China and Hong Kong | <sup>1)</sup> China includes Mainland China and Hong Kong |

---

<u>Q1 2026 compared to Q1 2025</u>

From an end market perspective, NXP experienced growth across all end markets versus the year-ago period.

------

Revenue in the Automotive end market was $1,782 million, an increase of $108 million or 6.5% versus the year-ago period. The increase was attributable to growth in mixed-signal products and processors.

Revenue in the Industrial & IoT end market was $628 million, an increase of $120 million or 23.6% versus the year-ago period. The increase was attributable to growth in processors and mixed-signal products.

Revenue in the Mobile end market was $391 million, an increase of $53 million or 15.7% versus the year-ago period. The increase was attributable to growth in mixed-signal products and processors.

Revenue in the Communication Infrastructure & Other end market was $380 million, an increase of $65 million or 20.6% versus the year-ago period. The increase was attributable to growth in processors, partially offset by declines in mixed-signal products.

When aggregating all end markets together and reviewing sales channel performance, revenue from distributors was $1,862 million, an increase of 338 million or 22.2% versus the year-ago period. Revenue from direct customers was $1,282 million, consistent with the year-ago period.

From a geographic perspective, revenue increased year-on-year in the Americas region by 27.9%, in the EMEA region by 8.5%, in the Asia Pacific region by 6.9%, and in the China region by 2.8%.

***Gross profit***

<u>Q1 2026 compared to Q1 2025</u>

Gross profit for the three months ended March 29, 2026, was $1,788 million, or 56.2% of revenue, compared to $1,560 million, or 55.0% of revenue for the three months ended March 30, 2025. The increase in gross margin is primarily driven by lower manufacturing costs (sourcing and cost efficiencies).

***Operating expenses***

<u>Q1 2026 compared to Q1 2025</u>

Operating expenses for the three months ended March 29, 2026, totaled $904 million, or 28.4% of revenue, compared to $855 million, or 30.2% of revenue for the three months ended March 30, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Research and development***

---

| | | | | |
|:---|:---|:---|:---|:---|
| ($ in millions, unless otherwise stated) | **Q1 2026** | **Q1 2025** | **% change** | **% change** |
| Research and development | 588 | 547 | 7.5 | % |
| As a percentage of revenue | 18.5% | 19.3% | (0.8) | ppt |

---

<u>Q1 2026 compared to Q1 2025</u>

R&D costs for the three months ended March 29, 2026, increased by $41 million, or 7.5%, when compared to the three months ended March 30, 2025, primarily driven by:

+ Increased variable compensation expenses ($28 million)

+ Increased personnel costs related to our acquisitions ($19 million)

- Lower share-based compensation costs ($7 million)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***• Selling, general and administrative***

---

| | | | | |
|:---|:---|:---|:---|:---|
| ($ in millions, unless otherwise stated) | **Q1 2026** | **Q1 2025** | **% change** | **% change** |
| Selling, general and administrative | 284 | 281 | 1.1 | % |
| As a percentage of revenue | 8.9% | 9.9% | (1.0) | ppt |

---

<u>Q1 2026 compared to Q1 2025</u>

SG&A costs for the three months ended March 29, 2026, increased by $3 million, or 1.1%, when compared to the three months ended March 30, 2025, primarily driven by:

+ Increased personnel and integration related costs of our acquisitions ($15 million)

+ Increased variable compensation expenses ($13 million)

- Lower legal fees ($23 million)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• *Amortization of acquisition-related intangible assets***

---

| | | | | |
|:---|:---|:---|:---|:---|
| ($ in millions, unless otherwise stated) | **Q1 2026** | **Q1 2025** | **% change** | **% change** |
| Amortization of acquisition-related intangible assets | 32 | 27 | 18.5 | % |
| As a percentage of revenue | 1.0% | 1.0% |  | ppt |

---

<u>Q1 2026 compared to Q1 2025</u>

Amortization of acquisition-related intangible assets for the three months ended March 29, 2026, increased by $5 million, or 18.5%, when compared to the three months ended March 30, 2025, primarily driven by amortization related to the recent acquisitions of TTTech Auto and Kinara.

***Other Income (Expense)***

Other income (expense) reflects an income of $621 million for the first quarter of 2026, compared to an income of $18 million in the first quarter of 2025. The increase was mainly driven by the gain on sale of $627 million related to the divestment of the MEMS Sensors business.

***Financial income (expense)***

The following table presents the details of financial income and expenses:

---

| | | |
|:---|:---|:---|
| ($ in millions, unless otherwise stated) | **Q1 2026** | **Q1 2025** |
| Interest income | 31 | 35 |
| Interest expense | (114) | (106) |
| Other financial income/ (expense) | (13) | (21) |
| Total | (96) | (92) |

---

<u>Q1 2026 compared to Q1 2025</u>

Financial income (expense) was an expense of $96 million for the three months ended March 29, 2026, compared to an expense of $92 million for the three months ended March 30, 2025. The change in financial income (expense) is primarily attributable to in increase in interest expense of $8 million due to the issuance of new bonds and EIB Loan B, offset by lower expenses due to the redemption of notes. Other financial expenses decreased mainly due to fair value adjustments in equity securities resulting in a gain of $1 million for the three months ended March 29, 2026, versus a loss of $6 million for the three months ended March 30, 2025.

***Benefit (provision) for income taxes***

Our provision for income taxes for 2026 is based on our EAETR of 19.9%, which is lower than the Netherlands statutory tax rate of 25.8%, primarily due to tax benefits from the Netherlands and foreign tax incentives.

---

| | | |
|:---|:---|:---|
| | **Q1 2026** | **Q1 2025** |
| Tax benefit (provision) calculated at EAETR | (280) | (119) |
| Discrete tax benefit (provision) items | 8 | (11) |
| Benefit (provision) for income taxes | (272) | (130) |
| Effective tax rate | 19.3% | 20.6% |

---

<u>Q1 2026 compared to Q1 2025</u>

The effective tax rate of 19.3% for the first quarter of 2026 was lower than the EAETR due to the income tax benefit for discrete items of $8 million. The discrete items are primarily related to the impact of foreign currency on income tax related items and changes in estimates for previous years.

The effective tax rate for the first quarter of 2026 was 19.3% compared to 20.6% for the same period in 2025, with discrete items in the respective periods impacting the rates accordingly. Excluding discrete items, the EAETR increased to 19.9% in 2026 from 18.8% in 2025, mainly as a result of a taxable capital gain and non-deductible goodwill associated with the divestiture of the MEMS Sensors business in the first quarter of 2026.

------

***Results Relating to Equity-accounted Investees***

<u>Q1 2026 compared to Q1 2025</u>

Results relating to equity-accounted investees amounted to a loss of $4 million for both the three months ended March 29, 2026, and the three months ended March 30, 2025.

***Non-controlling Interests***

<u>Q1 2026 compared to Q1 2025</u>

Non-controlling interests are related to the third-party share in the results of consolidated companies, predominantly SSMC. Their share of non-controlling interests amounted to a profit of $11 million for the three months ended March 29, 2026, compared to a profit of $7 million for the three months ended March 30, 2025.

**Liquidity and Capital Resources**

We derive our liquidity and capital resources primarily from our cash flows from operations. We continue to generate strong positive operating cash flows. At the end of the first quarter of 2026, our cash balance was $3,708 million, an increase of $441 million compared to December 31, 2025. Taking into account the available amount of the unsecured revolving credit facility of $3,000 million ("RCF"), we had access to $6,708 million of liquidity as of March 29, 2026. We currently use cash to fund operations, meet working capital requirements, for capital expenditures and for potential common stock repurchases, dividends and strategic investments. Based on past performance and current expectations, we believe that our current available sources of funds (including cash and cash equivalents, RCF of $3,000 million, plus anticipated cash generated from operations) will be adequate to finance our operations, working capital requirements, capital expenditures and potential dividends for at least the next twelve months.

---

| | | |
|:---|:---|:---|
| ($ in millions, unless otherwise stated) | **Q1 2026** | **Q1 2025** |
| Cash from operations | 793 | 565 |
| Capital expenditures | 79 | 139 |
| Cash to shareholders | 358 | 561 |

---

***Cash***

At March 29, 2026, our cash balance was $3,708 million of which $326 million was held by SSMC, our consolidated joint venture company with TSMC. Under the terms of our joint venture agreement with TSMC, a portion of this cash can be distributed by way of a dividend to us, but 38.8% of the dividend will be paid to our joint venture partner. During the first quarter of 2026, SSMC declared a dividend of $150 million, of which $75 million was paid in the first quarter, with 38.8% being paid to our joint venture partner.

***Capital expenditures***

Our cash outflows for capital expenditures were $79 million in the first three months of 2026, compared to $139 million in the first three months of 2025.

***Capital return***

In the first three months of 2026, we repurchased approximately $102 million of shares.

Under our Quarterly Dividend Program, interim dividends of $1.014 per ordinary share were paid on January 7, 2026 ($256 million) and dividends of $1.014 per ordinary share were paid on April 9, 2026 ($257 million).

***Debt***

Our total debt, inclusive of aggregate principal, unamortized discounts, premiums, debt issuance costs and fair value adjustments, amounted to $11,724 million as of March 29, 2026, a decrease of $498 million compared to December 31, 2025 ($12,222 million).

On January 5, 2026, we repaid the $500 million aggregate principal amount of outstanding 5.35% senior unsecured notes due March 1, 2026, at par using available cash.

On April 20, 2026, we repaid $750 million aggregate principal amount of outstanding 3.875% senior unsecured notes due June 18, 2026, at par using available cash.

As of March 29, 2026, we had outstanding fixed-rate notes with varying maturities for an aggregate principal amount of $10,749

------

million (collectively the "Notes"), of which $750 million is payable within 12 months. Future interest payments associated with the Notes total $2,777 million, with $396 million payable within 12 months.

As of March 29, 2026, the Company had outstanding loans with the European Investment Bank (EIB) with maturities in 2030 and 2031 for an aggregated principal amount of $1,040 million. Future interest payments associated with the EIB loans total $229 million, with $47 million payable within 12 months.

As of March 29, 2026, we had no commercial paper notes outstanding.

Our net debt position (see section Use of Certain Non-GAAP Financial Measures) at March 29, 2026, amounted to $8,016 million, compared to $8,955 million as of December 31, 2025.

***Additional Capital Requirements***

Expected working and other capital requirements are described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, in Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations". At March 29, 2026, other than for changes disclosed in the "Notes to Condensed Consolidated Financial Statements" and "Liquidity and Capital Resources" in this Quarterly Report, there have been no other material changes to our expected working and other capital requirements described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

**Cash flows**

Our cash and cash equivalents during the first three months of 2026 increased by $445 million (excluding the effect of changes in exchange rates on our cash position of $(4) million) as follows:

---

| | | |
|:---|:---|:---|
| ($ in millions, unless otherwise stated) | **Q1 2026** | **Q1 2025** |
| Net cash provided by operating activities | 793 | 565 |
| Net cash provided by (used for) investing activities | 508 | (216) |
| Net cash (used for) provided by financing activities | (856) | 345 |
| Increase in cash and cash equivalents | 445 | 694 |

---

***Cash Flow from Operating Activities***

For the first three months of 2026, our operating activities provided $793 million in cash. This was primarily the result of net income of $1,133 million, adjustments to reconcile the net income of $361 million and changes in operating assets and liabilities of $21 million. Adjustments to net income (loss) include non-cash items, such as gain on sale of assets of $(627 million), depreciation and amortization of $179 million, share-based compensation of $109 million and changes in deferred taxes (benefit) of $(28 million). Changes in operating assets and liabilities were primarily driven by a $115 million increase in receivables and other current assets due to the related timing of cash collection, $87 million decrease in inventories driven by lower external purchases, $182 million increase in other non-current assets due to payments to secure production supply (driven primarily by payments of $189 million to support the long-term capacity infrastructure of VSMC) and $231 million increase in accounts payable and other liabilities primarily due to a higher corporate tax accrual ($178 million) mainly driven by the capital gains tax on the divestiture of the MEMS Sensors business.

For the first three months of 2025 our operating activities provided $565 million in cash. This was primarily the result of net income of $497 million, adjustments to reconcile the net income of $299 million and changes in operating assets and liabilities of $(239 million). Adjustments to net income (loss) include non-cash items, such as depreciation and amortization of $209 million, share-based compensation of $127 million and changes in deferred taxes of $(27 million). Changes in operating assets and liabilities were primarily driven by a $110 million decrease in accounts payable and other liabilities as a result of lower purchase volumes and timing related to payments, $29 million increase in receivables and other current assets due to customer mix, and the related timing of cash collection and $106 million increase in other non-current assets due to payments to secure production supply with multiple vendors (driven primarily by payments of $125 million to support the long-term capacity infrastructure of VSMC).

***Cash Flow from Investing Activities***

Net cash proceeds from investing activities of $508 million for the first three months of 2026 was primarily driven by the proceeds of $878 million (net of adjustments) from the sale of our MEMS Sensors business, partially offset by $249 million for the purchase of investments (driven primarily by the capital contributions of $196 million into VSMC), capital expenditures of $79 million, and $42 million for the purchase of identified intangible assets.

------

Net cash used for investing activities amounted to $216 million for the first three months of 2025 and principally consisted of the cash outflows for capital expenditures of $139 million, $53 million for the purchase of investments (driven primarily by the capital contributions of approximately $20 million into VSMC and approximately $16 million into ESMC) and $25 million for the purchase of identified intangible assets, including EDA (electronic design automation).

***Cash Flow from Financing Activities***

Net cash used for financing activities of $856 million for the first three months of 2026 was primarily driven by the repurchase of long-term debt of $501 million, dividend payments to common stockholders of $256 million, and purchase of treasury shares and restricted stock unit holdings of $102 million.

Net cash proceeds from financing activities of $345 million for the first three months of 2025 was primarily driven by the proceeds from the issuance of commercial paper notes of $646 million, proceeds from issuance of long-term debt of $370 million, and the proceeds from the issuance of common stock through stock plans of $37 million, partially offset by the repayment of commercial paper notes of $146 million, dividend payments to common stockholders of $258 million and purchase of treasury shares and restricted stock unit holdings of $303 million.

------

**Information Regarding Guarantors of NXP (unaudited)**

***Summarized Combined Financial Information for Guarantee of Securities of Subsidiaries***

All debt instruments are guaranteed, fully and unconditionally, jointly and severally, by NXP Semiconductors N.V. and issued or guaranteed by NXP USA, Inc., NXP B.V. and NXP LLC, (together, the "Subsidiary Obligors" and together with NXP Semiconductors N.V., the "Obligor Group"). Other than the Subsidiary Obligors, none of the Company's subsidiaries (together the "Non-Guarantor Subsidiaries") guarantee the Notes. The Company consolidates the Subsidiary Obligors in its Consolidated Financial Statements and each of the Subsidiary Obligors are wholly owned subsidiaries of the Company.

All of the existing guarantees by the Company rank equally in right of payment with all of the existing and future senior indebtedness of the Obligor Group. There are no significant restrictions on the ability of the Obligor Group to obtain funds from respective subsidiaries by dividend or loan.

The following tables present summarized financial information of the Obligor Group on a combined basis, with intercompany balances and transactions between entities of the Obligor Group eliminated and investments and equity in the earnings of the Non-Guarantor Subsidiaries excluded. The Obligor Group's amounts due from, amounts due to, and intercompany transactions with Non-Guarantor Subsidiaries have been disclosed below the table, when material.

**Summarized Statements of Income**

---

| | |
|:---|:---|
| | **For the three months ended** |
| ($ in millions) | **March 29, 2026** |
| Revenue | 1742 |
| Gross Profit | 808 |
| Operating income | 762 |
| ***Net income*** | 436 |

---

**Summarized Balance Sheets**

---

| | | |
|:---|:---|:---|
| | **As of** | **As of** |
| ($ in millions) | **March 29, 2026** | **December 31, 2025** |
| Current assets | 3643 | 3182 |
| Non-current assets | 12404 | 12461 |
| ***Total assets*** | 16047 | 15643 |
| Current liabilities | 1667 | 2044 |
| Non-current liabilities | 11374 | 11348 |
| ***Total liabilities*** | 13041 | 13392 |
| Obligor's Group equity | 3006 | 2251 |
| ***Total liabilities and Obligor's Group equity*** | 16047 | 15643 |

---

NXP Semiconductors N.V. is the head of a fiscal unity for the corporate income tax and VAT that contains the most significant Dutch wholly owned group companies. The Company is therefore jointly and severally liable for the tax liabilities of the tax entity as a whole, and as such the income tax expense of the Dutch fiscal unity has been included in the net income of the Obligor Group.

The financial information of the Obligor Group includes sales executed through a Non-Guarantor Subsidiary single-billing entity as a sales agent on behalf of an entity in the Obligor Group. The Obligor Group has sales to non-guarantors (for the three months ended March 29, 2026: $168 million). The Obligor Group has amounts due from equity financing (March 29, 2026: $7,670 million; December 31, 2025: $5,520 million) and due to debt financing (March 29, 2026: $3,484 million; December 31, 2025: $2,695 million) with non-guarantor subsidiaries.

------

**Use of Certain Non-GAAP Financial Measures**

***Non-GAAP Financial Measures***

In addition to providing financial information on a basis consistent with U.S. generally accepted accounting principles ("US GAAP" or "GAAP"), NXP also provides selected financial measures on a non-GAAP basis which are adjusted for specified items. The adjustments made to achieve these non-GAAP financial measures or the non-GAAP financial measures as specified are described below, including the usefulness to management and investors.

In managing NXP's business on a consolidated basis, management develops an annual operating plan, which is approved by our Board of Directors, using non-GAAP financial measures. When measuring performance against this plan, management considers the actual or potential impacts on these non-GAAP financial measures from cost-reduction actions with the goal of increasing our gross margin and operating margin, as well as in assessing appropriate levels of research and development efforts. In addition, management relies upon these non-GAAP financial measures when making decisions about product spending, administrative budgets, and other operating expenses. We believe that these non-GAAP financial measures, when coupled with the GAAP results and the reconciliations to corresponding GAAP financial measures, provide a more complete understanding of the Company's results of operations and the factors and trends affecting NXP's business. We believe that they enable investors to make additional comparisons of our operating results, to assess our liquidity and capital position and to analyze financial performance excluding the effect of expenses unrelated to core operating performance, certain non-cash expenses and share-based compensation expense, which may obscure trends in NXP's underlying performance. This information also enables investors to compare financial results between periods where certain items may vary independent of business performance and allow for greater transparency with respect to key metrics used by management.

The presentation of these and other similar items in NXP's non-GAAP financial results should not be interpreted as implying that these items are non-recurring, infrequent, or unusual. These non-GAAP financial measures are provided in addition to, and not as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP.

---

| | | |
|:---|:---|:---|
| **Non-GAAP Adjustment or Measure** | **Definition** | **Usefulness to Management and Investors** |
| Purchase price accounting effects | Purchase price accounting ("PPA") effects reflect the fair value adjustments impacting acquisition accounting and other acquisition adjustments charged to the Consolidated Statement of Operations. This typically relates to inventory, property, plant and equipment, as well as intangible assets, such as developed technology and marketing and customer relationships acquired. The PPA effects are recorded within both cost of revenue and operating expenses in our US GAAP financial statements. These charges are recorded over the estimated useful life of the related acquired asset and thus are generally recorded over multiple years. | We believe that excluding these charges related to fair value adjustments for purposes of calculating certain non-GAAP measures allows the users of our financial statements to better understand the historic and current cost of our products, our gross margin, our operating costs, our operating margin, and also facilitates comparisons to peer companies. |
| Restructuring | Restructuring charges are costs associated with a restructuring plan and are primarily related to employee severance and benefit arrangements. Charges related to restructuring are recorded within both cost of revenue and operating expenses in our US GAAP financial statements | We exclude restructuring charges, including any adjustments to charges recorded in prior periods, for purposes of calculating certain non-GAAP measures because these costs do not reflect our core operating performance. These adjustments facilitate a useful evaluation of our core operating performance and comparisons to past operating results and provide investors with additional means to evaluate expense trends. |
| Share-based compensation | Share-based compensation consists of incentive expense granted to eligible employees in the form of equity-based instruments. Charges related to share-based compensation are recorded within both cost of revenue and operating expenses in our US GAAP financial statements. | We exclude charges related to share-based compensation for purposes of calculating certain non-GAAP measures because we believe these charges, which are non-cash, are not representative of our core operating performance as they can fluctuate from period to period based on factors that are not within our control, such as our stock price on the dates share-based grants are issued. We believe these adjustments provide investors with a useful view, through the eyes of management, of our core business model, how management currently evaluates core operational performance, and additional means to evaluate expense trends. |
| Other incidentals | Other incidentals consist of certain items which may be non-recurring, unusual, infrequent or directly related to an event that is distinct and non-reflective of the Company's core operating performance. These may include such items as process and product transfer costs, certain charges related to acquisitions and divestitures, litigation and legal settlements, costs associated with the exit of a product line, factory or facility, environmental or governmental settlements, and other items of similar nature. | We exclude these certain items which may be non-recurring, unusual, infrequent or directly related to an event that is distinct and non-reflective of the Company's core operating performance for purposes of calculating certain non-GAAP measures. These adjustments facilitate a useful evaluation of our core operating performance and comparisons to past operating results and provide investors with additional means to evaluate expense trends. |

---

------

---

| | | |
|:---|:---|:---|
| **Non-GAAP Adjustment or Measure** | **Definition** | **Usefulness to Management and Investors** |
| Non-GAAP Provision for income taxes | Non-GAAP provision for income taxes is NXP's GAAP provision for income taxes adjusted for the income tax effects of the adjustments to our GAAP measure, including PPA effects, restructuring costs, share-based compensation, other incidental items and certain other adjustments to financial income (expense) items. Additionally, adjustments are made for the income tax effect of any discrete items that occur in the interim period. Discrete items primarily relate to unexpected tax events that may occur as these amounts cannot be forecasted (e.g., the impact of changes in tax law and/or rates, changes in estimates or resolved tax audits relating to prior year tax provisions, the excess or deficit tax effects on share-based compensation, etc.). | The non-GAAP provision for income taxes is used to ascertain and present on a comparable basis NXP's provision for income tax after adjustments, the usefulness of which is described within this table. Additionally, the income tax effects of the adjustments to achieve the noted non-GAAP measures are used to determine NXP's non-GAAP net income (loss) attributable to stockholders and accordingly, our diluted non-GAAP earnings per share attributable to stockholders. |
| Free Cash Flow | Free Cash Flow represents operating cash flow adjusted for net additions to property, plant and equipment. | We believe that free cash flow provides insight into our cash-generating capability and our financial performance and is an efficient means by which users of our financial statements can evaluate our cash flow after meeting our capital expenditure. |
| Net debt | Net debt represents total debt (short-term and long-term) after deduction of cash and cash equivalents and short-term deposits. | We believe this measure provides investors with useful supplemental information about the financial performance of our business, enables comparison of financial results between periods where certain items may vary independent of business performance, and allow for greater transparency with respect of calculating our net leverage. |

---

The following are reconciliations of our most comparable US GAAP measures to our non-GAAP measures presented:

---

| | | | |
|:---|:---|:---|:---|
| ($ in millions) | **For the three months ended** | **For the three months ended** | **For the three months ended** |
|  | **March 29, 2026** | **December 31, 2025** | **March 30, 2025** |
| **GAAP gross profit** | $**1788** | $**1807** | $**1560** |
| &nbsp;&nbsp;&nbsp;PPA effects | (6) | (7) | (8) |
| &nbsp;&nbsp;&nbsp;Restructuring | 1 | (14) | (4) |
| &nbsp;&nbsp;&nbsp;Share-based compensation | (13) | (14) | (16) |
| &nbsp;&nbsp;&nbsp;Other incidentals | (9) | (71) | (3) |
| **Non-GAAP gross profit** | $**1815** | $**1913** | $**1591** |
| **GAAP Gross Margin** | **56.2%** | **54.2%** | **55.0%** |
| **Non-GAAP Gross Margin** | **57.1%** | **57.4%** | **56.1%** |
| GAAP research and development | $(588) | $(665) | $(547) |
| &nbsp;&nbsp;&nbsp;Restructuring | (2) | (89) | (7) |
| &nbsp;&nbsp;&nbsp;Share-based compensation | (57) | (58) | (64) |
| &nbsp;&nbsp;&nbsp;Other incidentals | (11) | (4) | (1) |
| Non-GAAP research and development | $(518) | $(514) | $(475) |
| GAAP selling, general and administrative | $(284) | $(359) | $(281) |
| &nbsp;&nbsp;&nbsp;PPA effects |  |  |  |
| &nbsp;&nbsp;&nbsp;Restructuring | (1) | (74) | (3) |
| &nbsp;&nbsp;&nbsp;Share-based compensation | (39) | (28) | (47) |
| &nbsp;&nbsp;&nbsp;Other incidentals | (4) | (15) | (20) |
| Non-GAAP selling, general and administrative | $(240) | $(242) | $(211) |
| **GAAP operating income (loss)** | $**1505** | $**744** | $**723** |

---

------

---

| | | | |
|:---|:---|:---|:---|
| ($ in millions) | **For the three months ended** | **For the three months ended** | **For the three months ended** |
|  | **March 29, 2026** | **December 31, 2025** | **March 30, 2025** |
| **GAAP operating income (loss)** | $**1505** | $**744** | $**723** |
| &nbsp;&nbsp;&nbsp;PPA effects | (38) | (41) | (40) |
| &nbsp;&nbsp;&nbsp;Restructuring | (2) | (177) | (14) |
| &nbsp;&nbsp;&nbsp;Share-based compensation | (109) | (100) | (127) |
| &nbsp;&nbsp;&nbsp;Other incidentals <sup>(i)</sup> | 602 | (92) |  |
| **Non-GAAP operating income (loss)** | $**1052** | $**1154** | $**904** |
| **GAAP Operating Margin** | **47.3%** | **22.3%** | **25.5%** |
| **Non-GAAP Operating Margin** | **33.1%** | **34.6%** | **31.9%** |
| **GAAP Income tax benefit (provision)** | $**(272)** | $**(131)** | $**(130)** |
| &nbsp;&nbsp;&nbsp;Income tax effect | (99) | 59 | 13 |
| **Non-GAAP Income tax benefit (provision)** | $**(173)** | $**(190)** | $**(143)** |
| (i) For the three months ended March 29, 2026, Other Incidentals includes the gain on sale of the MEMS Sensors business | (i) For the three months ended March 29, 2026, Other Incidentals includes the gain on sale of the MEMS Sensors business | (i) For the three months ended March 29, 2026, Other Incidentals includes the gain on sale of the MEMS Sensors business | (i) For the three months ended March 29, 2026, Other Incidentals includes the gain on sale of the MEMS Sensors business |

---

---

| | | | |
|:---|:---|:---|:---|
| ($ in millions) | **For the three months ended** | **For the three months ended** | **For the three months ended** |
|  | **March 29, 2026** | **December 31, 2025** | **March 30, 2025** |
| **Net cash provided by (used for) operating activities** | $**793** | $**891** | $**565** |
| &nbsp;&nbsp;&nbsp;Net capital expenditures on property, plant and equipment | (79) | (98) | (138) |
| **Non-GAAP free cash flow** | $**714** | $**793** | $**427** |

---

---

| | | | |
|:---|:---|:---|:---|
| ($ in millions) | **For the three months ended** | **For the three months ended** | **For the three months ended** |
|  | **March 29, 2026** | **December 31, 2025** | **March 30, 2025** |
| &nbsp;&nbsp;&nbsp;Long-term debt | $10974 | $10972 | $10226 |
| &nbsp;&nbsp;&nbsp;Short-term debt | 750 | 1250 | 1499 |
| Total debt | 11724 | 12222 | 11725 |
| &nbsp;&nbsp;&nbsp;Less: cash and cash equivalents | (3708) | (3267) | (3988) |
| **Net debt** | $**8016** | $**8955** | $**7737** |

---

------

**Item 3.&nbsp;&nbsp;&nbsp;&nbsp;Quantitative and Qualitative Disclosures About Market Risk**

There have been no material changes to the Company's market risk during the first three months of 2026. For a discussion of the Company's exposure to market risk, refer to the Company's market risk disclosures set forth in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K for the year ended December 31, 2025.

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp;Controls and Procedures**

*Evaluation of Disclosure Controls and Procedures*

Our management, with the participation of the Chief Executive Officer and Chief Financial Officer (Certifying Officers), evaluated the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended) on March 29, 2026. Based on that evaluation, the Certifying Officers concluded the Company's disclosure controls and procedures were effective as of March 29, 2026.

*Changes in Internal Control Over Financial Reporting*

There were no changes in the Company's internal control over financial reporting during the three months ended March 29, 2026, which were identified in connection with management's evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II — OTHER INFORMATION**

**Item 1.&nbsp;&nbsp;&nbsp;&nbsp;Legal Proceedings**

Not applicable.

**Item 1A. Risk Factors**

There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

**Purchases of Equity Securities by the Issuer and Affiliated Purchasers**

Our Board has approved the purchase of shares from participants in NXP's equity programs to satisfy participants' tax withholding obligations and this authorization will remain in effect until terminated by the Board. In August 2024, the Board approved the repurchase of shares up to a maximum of $2 billion (the "2024 Share Repurchase Program"). At March 29, 2026, there was approximately $1.5 billion remaining under the 2024 Share Repurchase Program.

The following share repurchase activity occurred under these programs during the three months ended March 29, 2026:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Period | <br>Total Number <br>of Shares <br>Purchased | Average Price <br>Paid per Share | Number of Shares Purchased as Part of Publicly Announced Buy Back Programs | Maximum Number of <br>Shares That May <br>Yet Be Purchased <br>Under the Buy Back Program | Number of Shares Purchased as Trade for Tax (1) |
| &nbsp;&nbsp;&nbsp;January 1, 2026 – February 1, 2026 | 158164 | $234.34 | 152990 | 6848316 | 5174 |
| &nbsp;&nbsp;&nbsp;February 2, 2026 – March 1, 2026 | 147025 | $231.64 | 141384 | 6677544 | 5641 |
| &nbsp;&nbsp;&nbsp;March 2, 2026 – March 29, 2026 | 156059 | 200.59 | 156059 | 7745827 |  |
| Total | 461248 |  | 450433 |  | 10815 |

---

<sup>(1)</sup> Reflects shares surrendered by participants to satisfy tax withholding obligations in connection with the Company's equity programs.

**Item 5. Other Information**

**Rule 10b5-1 Trading Plans**

None.

------

**Item 6.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits** 

---

| | |
|:---|:---|
| <br>**Exhibit**<br>**Number** | **Exhibit Description** |
| 3.1 | <u>[Articles of Association of NXP Semiconductors N.V. dated June 9, 2020 (incorporated by reference to Exhibit 3.1 to the Company's Quarterly Report on Form 10-Q of NXP Semiconductors N.V., filed on July 28, 2020)](https://www.sec.gov/Archives/edgar/data/1413447/000141344720000056/a2020-2q10xqexhibit31.htm)</u> |
| 4.1 | <u>[Second Amended and Restated Revolving Credit Agreement, dated as of February 6, 2026, among NXP B.V., NXP Funding LLC, the several lenders from time to time parties thereto, and Barclays Bank PLC, as administrative agent](https://www.sec.gov/Archives/edgar/data/1413447/000119312526041255/d90435dex41.htm)</u> (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K of NXP Semiconductors N.V. filed on February 6, 2026) |
| 4.2 | <u>[Second Amended and Restated Guaranty Agreement, dated as of February 6, 2026, among NXP Semiconductors N.V., NXP USA, Inc. and Barclays Bank PLC, as administrative agent](https://www.sec.gov/Archives/edgar/data/1413447/000119312526041255/d90435dex42.htm)</u> (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K of NXP Semiconductors N.V. filed on February 6, 2026) |
| 31.1\* | Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer |
| 31.2\* | Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer |
| 32.1\* | Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer |
| 101 | The following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended March 29, 2026, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations for the three months ended March 29, 2026 and March 30, 2025; (ii) Condensed Consolidated Statements of Comprehensive Income for the three months ended March 29, 2026 and March 30, 2025; (iii) Condensed Consolidated Balance Sheets as of March 29, 2026 and December 31, 2025; (iv) Condensed Consolidated Statements of Cash Flows for the three months ended March 29, 2026 and March 30, 2025; (v) Condensed Consolidated Statements of Changes in Equity for the three months ended March 29, 2026 and March 30, 2025; and (vi) Notes to the Unaudited Condensed Consolidated Financial Statements. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

---

| | |
|:---|:---|
| \* | Filed or furnished herewith. |
| + | Indicates management contract or compensatory plan or arrangement. |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: April 28, 2026

---

| | |
|:---|:---|
| **NXP Semiconductors N.V.** | **NXP Semiconductors N.V.** |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ William J. Betz |
| Name: William J. Betz, CFO | Name: William J. Betz, CFO |

---

------

**Exhibit 31.1**

**CERTIFICATION**

I, Rafael Sotomayor, certify that:

1. I have reviewed this quarterly report on Form 10-Q of NXP Semiconductors N.V.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

Date: April 28, 2026

---

| | |
|:---|:---|
| By: | /s/ Rafael Sotomayor |
|  | Rafael Sotomayor |
|  | President & Chief Executive Officer |

---

------

**Exhibit 31.2**

**CERTIFICATION**

I, William J. Betz, certify that:

1. I have reviewed this quarterly report on Form 10-Q of NXP Semiconductors N.V.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

Date: April 28, 2026

---

| | |
|:---|:---|
| By: | /s/ William J. Betz |
|  | William J. Betz |
|  | Chief Financial Officer |

---

------

**Exhibit 32.1**

**CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER**

**PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

I, Rafael Sotomayor, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of NXP Semiconductors N.V. on Form 10-Q for the period ended March 29, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of NXP Semiconductors N.V. at the dates and for the periods indicated.

Date: April 28, 2026

---

| | |
|:---|:---|
| By: | /s/ Rafael Sotomayor |
|  | Rafael Sotomayor |
|  | President & Chief Executive Officer |

---

I, William J. Betz, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of NXP Semiconductors N.V. on Form 10-Q for the period ended March 29, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of NXP Semiconductors N.V. at the dates and for the periods indicated.

Date: April 28, 2026

---

| | |
|:---|:---|
| By: | /s/ William J. Betz |
|  | William J. Betz |
|  | Chief Financial Officer |

---